Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
0.5950
-0.1050 (-15.00%)
Oct 8, 2026, 10:43 AM HKT
HKG:1643 Revenue
Modern Chinese Medicine Group had revenue of 118.54M CNY in the half year ending June 30, 2026, with 54.70% growth. This brings the company's revenue in the last twelve months to 198.95M, down -1.61% year-over-year. In the year 2025, Modern Chinese Medicine Group had annual revenue of 145.17M, down -32.18%. That makes Modern Chinese Medicine Group the world's 31,483rd largest company by revenue and 1,893rd in Hong Kong.
Revenue (ttm)
198.95M CNY
Revenue Growth
-1.61%
P/S Ratio
2.19
Revenue / Employee
1.05M CNY
Employees
189
Market Cap
428.40M HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 145.17M | -68.89M | -32.18% |
| Dec 31, 2024 | 214.07M | -130.01M | -37.78% |
| Dec 31, 2023 | 344.08M | -55.58M | -13.91% |
| Dec 31, 2022 | 399.66M | 38.96M | 10.80% |
| Dec 31, 2021 | 360.70M | 52.00M | 16.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 48.06B |
| WuXi Biologics | 27.27B |
| Hansoh Pharmaceutical Group Company | 18.35B |
| Innovent Biologics | 18.13B |
| Hospital Corporation of China | 1.69B |
| Vincent Medical Holdings | 964.90M |
| Kato (Hong Kong) Holdings | 353.78M |
| MedSci Healthcare Holdings | 303.14M |